Calls Purchased on NPS Pharmaceuticals

Shares of NPS Pharmaceuticals NPSP are higher on the session by 2.73%, currently trading at $7.16. The stock has been moving largely lower over the past three months and is currently trading below the 50-day moving average. Options traders are buying calls on the name today. A short while ago the August 2011 $10 call traded 1,000 times on open interest of 2,501 contracts. Overall call volume is now running at 20.29x the daily average with 93% of all calls traded being purchases on the offer. NPS Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of new treatment options for patients with gastrointestinal and endocrine disorders and medical needs.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: OptionsBiotechnologyHealth Care
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!